{"id":"W2993178565","doi":"10.1111/bjh.16306","title":"Day 15 bone marrow minimal residual disease predicts response to blinatumomab in relapsed/refractory paediatric B‐ALL","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Amgen","keywords":"Blinatumomab; Medicine; Minimal residual disease; Refractory (planetary science); Bone marrow; Bone marrow failure; Immunology; Internal medicine; Oncology; Antibody; Stem cell; CD19; Haematopoiesis; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003345163,0.000644351,0.002832851,0.002919077,0.00007526483,0.0001041461,0.0009761595,0.001917406,0.0003485681],"category_scores_gemma":[0.01455813,0.0006989776,0.0005390704,0.0007797078,0.0003596082,0.0002080913,0.0004868363,0.007394317,0.0004032709],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001754832,"about_ca_system_score_gemma":0.007800391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007501745,"about_ca_topic_score_gemma":0.0000333497,"domain_scores_codex":[0.9902804,0.002459502,0.002405429,0.0009317701,0.002315688,0.001607175],"domain_scores_gemma":[0.9922107,0.003972255,0.001163612,0.0008519146,0.0008647693,0.0009367196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008418959,0.0002169042,0.0008693445,0.0005956151,0.0001480081,0.46135,0.00008103659,0.000005231029,0.0001012834,9.799727e-7,0.5277998,0.0004127815],"study_design_scores_gemma":[0.01630317,0.002971659,0.01699486,0.004017398,0.0007455688,0.4608162,0.0000600876,0.00006156111,0.00004083139,0.00007854342,0.4972128,0.0006973162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.6153192,0.01138368,0.00002257368,0.3701826,0.001526572,0.001027814,0.0002918511,0.00005052591,0.0001951493],"genre_scores_gemma":[0.4254062,0.002064903,0.002207488,0.5408762,0.01329442,0.000126438,0.0005458723,0.000698362,0.01478003],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.189913,"threshold_uncertainty_score":0.9995461,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01426288508101855,"score_gpt":0.2729198481157316,"score_spread":0.2586569630347131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}